Thyroid and Hashimoto's

Four separate questions live under the word thyroid: function, autoimmunity, structure, and whether treatment is set correctly.

20 answers·Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Understanding thyroid tests4

Diagnosis and antibodies6

Treatment and medication6

Symptoms and daily life4

Not sure which one you need?

Thyroid results are read as patterns, not as single values. TSH and free T4 move in opposite directions in primary thyroid disease, and it is the combination that names the problem.

PatternWhat it usually meansWhat a clinician does next
TSH high, free T4 lowOvert primary hypothyroidismConfirm, check TPO antibodies for cause, begin thyroid hormone replacement
TSH high, free T4 normalSubclinical hypothyroidismRepeat before labelling it, check TPO antibodies, then weigh degree of elevation, symptoms, age and pregnancy plans
TSH low, free T4 or free T3 highThyrotoxicosisEstablish the cause before treating it, since Graves disease, a hot nodule and thyroiditis are managed differently
TSH low, free T4 normalSubclinical hyperthyroidismRepeat, then assess heart rhythm and bone density risk, which drive the decision to treat
TSH low, free T4 lowA pituitary pattern, not a thyroid oneStop interpreting TSH alone and evaluate pituitary function
TSH and free T4 both normal, symptoms presentThyroid function is not the explanation for these symptomsLook at ferritin, B12, glucose and insulin, sleep, and perimenopause rather than adjusting a thyroid dose
TSH normal on levothyroxine, symptoms persistAn adequacy question, not a diagnosis questionReview timing, food and interfering medicines, and confirm the draw was 6 to 8 weeks after the last dose change

Find the row that matches your report, then read the answers below on that specific pattern.

Background: how to think about thyroid and hashimoto's A longer read from Dr. Sater, for context rather than a specific question

The most common misunderstanding in this area is that the thyroid is one question with one answer. Patients arrive saying their thyroid was checked, meaning a single TSH was drawn once, and they treat that number as a verdict on the entire gland. It is not. Four separate clinical questions live under the word thyroid, and a TSH result speaks to only one of them.

What this area actually covers

The four questions are these. Is the gland making enough hormone right now. Is the immune system attacking it. Is there something structurally wrong with it. And if you are already on treatment, is that treatment set correctly. Each question has its own test. Function is TSH read alongside free T4. Autoimmunity is TPO and thyroglobulin antibodies. Structure is ultrasound. Treatment adequacy is a TSH drawn at the right interval, on a dose taken the right way.

These four questions do not answer each other, and most confusion in thyroid care comes from treating one as if it settled another. Positive TPO antibodies say the immune system is involved. They say nothing about whether a levothyroxine dose is correct. A nodule found on ultrasound says nothing about whether you are hypothyroid. Hypothyroidism itself is common: the NIDDK puts it at nearly 5 in 100 Americans aged 12 and over, and notes that most cases are mild or produce few obvious symptoms. Common and mostly quiet is an awkward combination, because it makes the diagnosis both easy to make and easy to over-attribute.

Where the standard workup goes wrong

Three failures show up repeatedly. The first is a single TSH treated as final. TSH moves with time of day, recent illness, biotin supplements and normal biological variation, so one borderline result is a reason to repeat the test, not a reason to start a tablet. The second is the opposite: a panel of twelve thyroid markers ordered at once, including several that no professional society recommends, which produces flagged values that then have to be explained away.

The third is timing. The American Thyroid Association advises checking blood 6 to 8 weeks after starting or changing a thyroid hormone dose. Blood drawn at three weeks reflects a system still moving, and dose decisions made on that number tend to overshoot. There is a fourth, quieter failure worth naming: once a thyroid label exists in a chart, later symptoms get assigned to it by default, and low ferritin, poor sleep, perimenopause or a medication side effect goes unexamined for years.

What is genuinely contested, and by whom

The upper limit of normal for TSH has been argued over for two decades. Martin Surks and colleagues argued in the Journal of Clinical Endocrinology and Metabolism in 2005 that the reference range should remain unchanged, against a position that it should be lowered toward 2.5 mIU/L. The major societies did not adopt the narrower limit for non-pregnant adults, but plenty of practitioners treat 2.5 as a target. Patients need to know that a clinician calling their TSH of 3.2 abnormal is taking a side in an unsettled argument, not reading a settled fact.

Combination therapy with liothyronine is the second live question. A joint consensus document from the American, British and European thyroid associations, published in Thyroid in 2021, concluded that existing trials carried too many limitations to settle whether adding T3 helps, and set out how better trials should be designed. Reverse T3 is different: it is not contested inside endocrinology at all. The American Thyroid Association states plainly that in healthy, non-hospitalized people, measuring reverse T3 "does not help determine whether hypothyroidism exists or not, and is not clinically useful." The disagreement there is between the specialty and the direct-to-consumer testing market.

What changed recently

The specialty's own document set has aged unevenly, and that matters for what your clinician was taught. The ATA guideline for treating hypothyroidism still dates from 2014. The hyperthyroidism guideline is from 2016. The differentiated thyroid cancer guideline was rewritten in 2025, and the guideline covering preconception, pregnancy and postpartum thyroid disease was replaced in 2026. So advice about thyroid function in pregnancy given even two years ago may no longer match current recommendations, while the core rules for dosing levothyroxine have not moved in a decade.

The answers below are grouped along those four questions. If you are trying to understand a result you already have, start with the pattern table above and then read the answer that matches your pattern. If you are on treatment and still feel unwell, the answers on absorption, dose timing and what a normal TSH does not rule out are the ones to read first.

Other topics

Every answer here is written and reviewed by a board-certified endocrinologist. To have that judgment applied to your own history, book a consultation with Dr. Sater.

Book a consultation